Building a financial plan for pharmacy clinical services

Expanding into a clinical service can strengthen a community pharmacy’s role in local healthcare, but good intentions do not create a sustainable business model. A vaccination clinic, medication review program, opioid dependence support service or chronic disease consultation area requires time, staff, equipment, documentation and careful financial planning.

For an Australian pharmacy, the numbers are shaped by PBS dispensing income, private fees, state and federal programs, workforce costs and the practical realities of serving a busy suburb, regional town or remote community. A clear plan helps owners decide which service to launch, how quickly to scale it and what evidence will show whether it is worth continuing.

Define the clinical service and its commercial purpose

Start by describing the service in operational terms rather than using a broad label such as “expanded clinical care”. Specify the patient group, appointment length, professional qualifications, consultation setting, required equipment, documentation standards and referral pathways. For example, a pharmacist-led medication review may involve a 30-minute appointment, follow-up calls and communication with a general practitioner, while a vaccination service may be shorter but require cold-chain controls, observation time and emergency equipment.

The commercial purpose also needs to be explicit. A service may generate direct consultation fees, increase retention of regular patients, support dispensing adherence or create stronger referral relationships with nearby GPs and allied health providers. These benefits should be recorded separately. A program that produces modest direct revenue but fills quiet trading periods may be valuable, while a popular service that disrupts dispensary workflow could reduce overall profitability.

Consider the local care gap. In outer Melbourne, a pharmacy may encounter long waits for GP appointments and demand for quick medication advice. In a regional centre such as Bendigo or Toowoomba, the service may be valuable because patients travel considerable distances for specialist care. In remote communities, access, workforce availability and transport can matter more than appointment volume. The plan should respond to the population nearby, rather than copying a model designed for another pharmacy.

Establish a reliable baseline

Before forecasting growth, examine the pharmacy’s existing performance. Review dispensing volume, trading hours, average basket value, gross profit by category, labour costs, professional service income and the number of unused consultation-room hours. Break the information into ordinary trading periods, school holidays, weekends and seasonal peaks. A service that appears affordable across a full year may place unacceptable pressure on cash flow during quieter months.

Calculate the true cost of staff time. Include the pharmacist’s salary or opportunity cost, casual loading, superannuation, payroll tax where applicable, training time, administration and leave coverage. If a pharmacist spends 20 minutes preparing for an appointment and 30 minutes with the patient, the service consumes 50 minutes even if the consultation itself is advertised as half an hour. Reception, booking, cleaning and follow-up work should be included as well.

Separate fixed costs from variable costs. Fit-out, privacy screens, a clinical chair, a laptop, secure storage and point-of-care devices may be paid upfront or financed. Consumables, personal protective equipment, sharps disposal, printing, software subscriptions and payment fees usually rise with each appointment. A baseline budget should show the existing position before the expansion, allowing the owner to see whether the new service genuinely improves the pharmacy’s contribution.

Build the investment and operating budget

List startup costs in a separate schedule. Typical items include room modifications, signage, clinical furniture, refrigeration or monitoring equipment, software integration, staff education, professional indemnity adjustments and launch marketing. Obtain written quotes wherever possible. A supplier’s advertised price may exclude delivery, installation, calibration, service contracts or GST, so the budget should make those assumptions visible.

Then prepare a monthly operating budget for at least 12 months. Include expected appointment numbers, fee income, rebates or program payments, wages, consumables, rent allocation, insurance, merchant charges and administration. Use conservative, expected and strong-demand scenarios. The conservative case should reflect a slow referral pipeline and several cancelled appointments, not an implausible disaster scenario.

A break-even calculation gives the team a practical target. If monthly fixed costs are $6,000, the average fee is $75 and variable cost per appointment is $15, the service needs 100 appointments a month to cover those costs before tax. That is around five appointments on each weekday, but the number must be adjusted for leave, no-shows and uneven demand. A written cancellation policy, reminder process and waitlist can protect the forecast.

Budget for working capital as well. Payments from programs or third parties may not arrive at the same time as wages and supplier invoices. GST treatment, income tax instalments and equipment finance repayments can create additional pressure. A separate bank account or accounting class for the service makes it easier to monitor performance and prevents early losses from disappearing inside the general pharmacy figures.

Map revenue, funding and patient affordability

Revenue may come from several sources, and each should be forecast separately. Private consultation fees are relatively easy to model but depend on patient willingness to pay. Government-funded or commissioned services may have eligibility rules, claiming requirements and changing payment arrangements. Manufacturer-supported education or sponsored activities require careful governance so that commercial interests do not compromise clinical independence.

Australian pharmacies also need to distinguish between services covered by existing arrangements and services that can be charged privately. PBS dispensing remuneration does not automatically fund every clinical activity performed during a prescription interaction. Check current guidance from the Pharmacy Programs Administrator, relevant state or territory health department and professional bodies before relying on a payment stream. A service linked to the 8CPA environment, vaccination policy or opioid dependence treatment may carry specific documentation, supervision or reporting obligations.

Affordability is part of the financial design. A fee that maximises margin may exclude pensioners, young families or people managing several medicines. Consider concession pricing, employer-funded appointments, bundled follow-up, payment plans where appropriate and referral to publicly funded alternatives. The pharmacy should never pressure a patient into a paid service when a clinically suitable free pathway exists.

A sound plan also includes a policy for unpaid clinical time. Pharmacists often answer brief questions, coordinate with prescribers and support vulnerable patients without billing for every interaction. That work has clinical value, but if it becomes extensive, the service model may need triage rules, appointment limits or funding from another source. The aim is to make invisible labour visible without turning every patient conversation into a sales opportunity.

Match staffing, workflow and compliance

A clinical expansion must fit the daily rhythm of the dispensary. Map the patient journey from booking to consent, consultation, documentation, payment, follow-up and referral. Identify what happens when the pharmacist is interrupted by a queue, a controlled-drug request or an urgent prescriber call. If the only trained clinician is pulled away repeatedly, appointment delays and patient dissatisfaction will affect both service quality and revenue.

Workforce planning should cover minimum staffing and absence cover. Determine whether the service requires a pharmacist with additional training, a credentialed nurse, a pharmacy technician for preparation or an administrator for bookings and claims. Calculate the cost of paid education and the lost dispensing time during training. Rosters should protect clinical appointments rather than treating them as tasks that can be squeezed between prescriptions.

Clinical governance is a financial issue as well as a professional obligation. Include policies for privacy, informed consent, incident reporting, record retention, infection prevention, emergency response and escalation to a GP or hospital. For services involving substance dependence, mental health or suicide risk, staff need clear boundaries and referral processes. Resources such as opioid care guidance can support broader thinking about how community pharmacies engage patients who may face stigma or fragmented care.

Protect the consultation environment. A private room, accessible entry, interpreter arrangements and discreet booking process can increase uptake among people who would avoid discussing sensitive matters at the counter. These changes may cost money initially, yet they can improve attendance, trust and continuity. Include them in the business case instead of treating them as optional decoration.

Use a measured pilot and decision gates

Launching a pilot is safer than committing immediately to a large fit-out or multiple new services. Select a defined period, such as 12 weeks, with a limited appointment schedule and clear inclusion criteria. Track bookings, completed consultations, cancellations, average fee, labour time, consumable cost, referrals, repeat visits and patient feedback. Compare actual figures with the assumptions in the forecast every fortnight.

Financial performance should be assessed at service level. Report gross revenue, direct labour, direct consumables, allocated overhead and contribution margin. Contribution margin shows what remains to support the pharmacy after costs that rise with activity have been paid. It is more informative than gross sales alone. A service can have impressive turnover while consuming more clinical labour than it returns.

Set decision gates before launch. For example, the service might need to achieve 70 completed appointments per month, an average patient rating above a defined threshold, accurate documentation in 95 per cent of records and a contribution margin sufficient to cover its room and administration costs. If those measures are missed, the response may be to change appointment times, revise pricing, strengthen referral relationships or pause the program.

Keep a risk register alongside the financial spreadsheet. Risks may include a change to government funding, equipment failure, staff turnover, low referral volume, privacy incidents, adverse clinical events or a competing provider opening nearby. Assign each risk an owner, an early warning sign and a response. When the team reviews the plan monthly, it can act on evidence rather than allowing enthusiasm or sunk costs to drive decisions.

Strengthen controls and long-term value

Cash handling and reconciliation deserve attention when a pharmacy adds private services. Use a consistent point-of-sale category, issue receipts, reconcile online and terminal payments, and check that refunds are authorised. Avoid mixing clinical service deposits with personal accounts or informal payment arrangements. When assessing new payment tools or fast-settlement claims, treat promotional material cautiously; discussions of rapid payout models illustrate why speed of payment should never replace due diligence, compliance checks and a clear understanding of transaction risk.

Marketing should be evidence-based and locally focused. Explain the service through the pharmacy website, SMS reminders, community noticeboards, local sporting clubs, aged-care connections and conversations with nearby health professionals. In Australia, a referral relationship with a GP clinic, Aboriginal Community Controlled Health Organisation or local hospital discharge team may be more valuable than a broad online advertising campaign. Obtain consent before sharing patient information and avoid claims that overstate what the service can achieve.

Track non-financial value as well. Record improved medicine adherence, resolved therapy problems, successful referrals, reduced missed appointments and patient stories obtained with permission. These outcomes can support future funding applications and help the pharmacy demonstrate its role in the community. Professional commentary and practical ideas from community pharmacy leaders may also help owners compare service models and think beyond simple transaction volume.

Review the financial plan quarterly after the pilot. Update wages, supplier prices, appointment demand, funding rules and equipment costs. Decide whether to maintain, expand, redesign or retire the service. A disciplined pharmacy does not regard a pause as failure; it uses evidence to protect staff capacity, patient safety and the broader business.

A clinical service expansion becomes sustainable when its purpose, price, workforce, governance and cash flow are connected. Begin with a modest pilot, document every assumption and give the team permission to adjust the model as real patient demand becomes clear. Build the spreadsheet with your pharmacist team, bookkeeper and relevant clinical partners, then review the first 90 days against the agreed measures and make the next investment only when the evidence supports it.